Literature DB >> 12624789

Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.

G Reifenberger1, K Kaulich, O D Wiestler, I Blümcke.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare, superficially located astrocytic glioma of children and young adults, which is associated with a relatively favorable prognosis. Here we report on the expression of the hematopoietic progenitor cell and vascular endothelial cell associated antigen CD34 in PXAs. We found CD34 immunoreactivity in various fractions of tumor cells in 44 of 60 PXAs investigated (73%). CD34 expression was more common in PXAs of WHO grade II (37 of 44 tumors, 84%) than in PXAs with anaplastic features (7 of 16 tumors, 44%). Immunoreactivity for CD34 was also commonly detected in single or clustered dysplastic neural cells within the cerebral cortex adjacent to the PXAs. Reverse transcription-PCR revealed that PXAs express the full-length CD34 transcript and a known splice variant encoding a truncated form of CD34. Both transcripts were detectable at higher levels in PXAs as compared to diffuse astrocytomas and non-neoplastic brain tissue. Taken together, our findings demonstrate that PXAs frequently express CD34 not only in vascular endothelial cells but also in tumor cells and in dysplastic cells of the adjacent cortex. Therefore, immunostaining for CD34 may be a helpful tool for the histological differential diagnosis of PXAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12624789     DOI: 10.1007/s00401-002-0652-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

Review 1.  Imaging surgical epilepsy in children.

Authors:  Charles Raybaud; Manohar Shroff; James T Rutka; Sylvester H Chuang
Journal:  Childs Nerv Syst       Date:  2006-07-13       Impact factor: 1.475

Review 2.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  High-grade glioma before and after treatment with radiation and Avastin: initial observations.

Authors:  Ingeborg Fischer; Clare H Cunliffe; Robert J Bollo; Shahzad Raza; David Monoky; Luis Chiriboga; Erik C Parker; John G Golfinos; Patrick J Kelly; Edmond A Knopp; Michael L Gruber; David Zagzag; Ashwatha Narayana
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

4.  Pathophysiologic characteristics of balloon cells in cortical dysplasia.

Authors:  Hyun-Sik Oh; Min-Cheol Lee; Hyung-Seok Kim; Ji-Shin Lee; Jae-Hyuk Lee; Myeong-Kyu Kim; Young-Jong Woo; Jae-Hyoo Kim; Hyoung-Ihl Kim; Seung-Up Kim
Journal:  Childs Nerv Syst       Date:  2007-09-26       Impact factor: 1.475

5.  Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.

Authors:  Yan-Xi Li; Abudumijiti Aibaidula; Zhifeng Shi; Hong Chen; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Ryan Rui Yang; Danny Tat-Ming Chan; Wai Sang Poon; Ka Lok Ryan Lee; Ying Mao; Jinsong Wu; Aden Ka-Yin Chan; Liangfu Zhou; Ho-Keung Ng
Journal:  J Neurooncol       Date:  2018-05-14       Impact factor: 4.130

Review 6.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

Review 7.  A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.

Authors:  Ingmar Blumcke; Eleonora Aronica; Horst Urbach; Andreas Alexopoulos; Jorge A Gonzalez-Martinez
Journal:  Acta Neuropathol       Date:  2014-05-25       Impact factor: 17.088

8.  Parieto-temporal pleomorphic xanthoastrocytoma in a black African child.

Authors:  Aaron Musara; Kazadi K Kalangu; Maximillan N Dzowa; Wilfred Muteweye; Rudo Mutasa
Journal:  Asian J Neurosurg       Date:  2017 Apr-Jun

9.  MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.

Authors:  Laura-Nanna Lohkamp; Maren Schinz; Claire Gehlhaar; Katrin Guse; Ulrich-Wilhelm Thomale; Peter Vajkoczy; Frank L Heppner; Arend Koch
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Pleomorphic xanthoastrocytoma with anaplastic features: A rare case report and review of literature with reference to current management.

Authors:  M R Patibandla; Madhukar Nayak; A K Purohit; Amit Kumar Thotakura; Megha Uppin; Sundaram Challa
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.